| 英文别名 |
CO 1686;CO-1686 (AVL-301);CO-1686;N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide;N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;Pyridostadin;Rociletinib;Rociletinib(CO-1686);(N-(3-(2-(4-(4-acetylpiperazin-1-yl)-2-methoxyphenylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)phenyl)acrylamide);AVL-301;CNX-419;N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide;S7284,CNX-419,AVL-301;CO-1686(Rociletinib);CO1686;72AH61702G;Rociletinib [USAN:INN];Tube721;Rociletinib (USAN/INN);GTPL7966;SC;Rociletinib (CO-1686, AVL-301);AMY9218;1374640-70-6;HMS3653G08;HUFOZJXAKZVRNJ-UHFFFAOYSA-N;HY-15729;UNII-72AH61702G;DTXSID801025958;DB11907;EX-A228;US8975249, I-4;D10858;Rociletinib; CO-1686;BCP07085;CS-1631;SCHEMBL4177736;MFCD26793864;NCGC00386293-08;BDBM149404;SW219475-1;AC-27467;NSC779405;Rociletinib [USAN];s7284;DA-34963;NSC800872;ROCILETINIB [WHO-DD];CHEMBL3545308;AKOS032949985;NSC-800872;AS-17009;NSC783605;SB16488;N-(3-{[2-{[4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide;Rociletinib (CO-1686);CCG-270031;ROCILETINIB [INN];Rociletinib (CO-1686)?;2-PROPENAMIDE, N-(3-((2-((4-(4-ACETYL-1-PIPERAZINYL)-2-METHOXYPHENYL)AMINO)-5-(TRIFLUOROMETHYL)-4-PYRIMIDINYL)AMINO)PHENYL)-;NS00073137;N-[3-[[2-[[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide;AKOS025401943;Q27088606;NSC-779405;NSC-783605;BRD-K33610132-001-02-9 |
